Cargando…

Determining the Time of Booster Dose Based on the Half-Life and Neutralization Titers against SARS-CoV-2 Variants of Concern in Fully Vaccinated Individuals

Although mRNA-based COVID-19 vaccines reduce the risk of severe disease, hospitalization and death, vaccine effectiveness (VE) against infection and disease from variants of concern (VOC) wanes over time. Neutralizing antibodies (NAb) are surrogates of protection and are enhanced by a booster dose,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dai, Yu-Ching, Lin, Yen-Chia, Ching, Lauren L., Tsai, Jih-Jin, Ishikawa, Kyle, Tsai, Wen-Yang, Chen, John J., Nerurkar, Vivek R., Wang, Wei-Kung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10434144/ https://www.ncbi.nlm.nih.gov/pubmed/37428104 http://dx.doi.org/10.1128/spectrum.04081-22

Ejemplares similares

Identification of severe acute respiratory syndrome coronavirus 2 breakthrough infections by anti-nucleocapsid antibody among fully vaccinated non-healthcare workers during the transition from the delta to omicron wave
por: Dai, Yu-Ching, et al.
Publicado: (2022)

A real-time and high-throughput neutralization test based on SARS-CoV-2 pseudovirus containing monomeric infrared fluorescent protein as reporter
por: Tsai, Wen-Yang, et al.
Publicado: (2021)

COVID-19 vaccination and booster induced authentic-virus neutralizing antibody response is superior to SARS-CoV-2 natural infection induced response
por: Ching, Lauren L., et al.
Publicado: (2022)

Factors influencing neutralizing antibody titers elicited by coronavirus disease 2019 vaccines
por: Kung, Yu-An, et al.
Publicado: (2023)

Titers and breadth of neutralizing antibodies against SARS-CoV-2 variants after heterologous booster vaccination in health care workers primed with two doses of ChAdOx1 nCov-19: A single-blinded, randomized clinical trial
por: Chuang, Chih-Hsien, et al.
Publicado: (2022)

Recombinant protein subunit vaccine booster following two-dose inactivated vaccines dramatically enhanced anti-RBD responses and neutralizing titers against SARS-CoV-2 and Variants of Concern
por: Ai, Jingwen, et al.
Publicado: (2021)

Comparing the performance of dengue virus IgG and IgG-capture enzyme-linked immunosorbent assays in seroprevalence study
por: Tsai, Jih-Jin, et al.
Publicado: (2023)

Correction to: Comparing the performance of dengue virus IgG and IgG-capture enzyme-linked immunosorbent assays in seroprevalence study
por: Tsai, Jih-Jin, et al.
Publicado: (2023)

Characterization of the Ectodomain of the Envelope Protein of Dengue Virus Type 4: Expression, Membrane Association, Secretion and Particle Formation in the Absence of Precursor Membrane Protein
por: Hsieh, Szu-Chia, et al.
Publicado: (2014)

Neutralization antibody titers against SARS-CoV-2 in an infant born to a mother with COVID-19
por: Chen, Yi-Ching, et al.
Publicado: (2021)

A high-throughput and multiplex microsphere immunoassay based on non-structural protein 1 can discriminate three flavivirus infections
por: Tyson, Jasmine, et al.
Publicado: (2019)

A Booster Dose of CoronaVac Increases Neutralizing Antibodies and T Cells that Recognize Delta and Omicron Variants of Concern
por: Schultz, Bárbara M., et al.
Publicado: (2022)

High-titer anti-interferon-γ neutralizing autoantibodies linked to opportunistic infections in patients with adult-onset still's disease
por: Chen, Po-Ku, et al.
Publicado: (2023)

Is There Any Opportunity to Provide an HBV Vaccine Booster Dose before Anti-Hbs Titer Vanishes?
por: Papadopoli, Rosa, et al.
Publicado: (2020)

Impact of homologous and heterologous boosters in neutralizing antibodies titers against SARS-CoV-2 Omicron in solid-organ transplant recipients
por: Gaete-Argel, Aracelly, et al.
Publicado: (2023)

No correlation of neutralizing antibody titers against the Omicron variant after a booster dose of COVID-19 vaccines with subsequent breakthrough Omicron infections among healthcare workers
por: Lee, Jeongjae, et al.
Publicado: (2022)

Anti-HCV antibody titer highly predicts HCV viremia in patients with hepatitis B virus dual-infection
por: Liu, Hung-Yin, et al.
Publicado: (2021)

A fully automated sample-to-answer PCR system for easy and sensitive detection of dengue virus in human serum and mosquitos
por: Tsai, Jih-Jin, et al.
Publicado: (2019)

C-Terminal Helical Domains of Dengue Virus Type 4 E Protein Affect the Expression/Stability of prM Protein and Conformation of prM and E Proteins
por: Tsai, Wen-Yang, et al.
Publicado: (2012)

Seroprevalence of dengue virus in two districts of Kaohsiung City after the largest dengue outbreak in Taiwan since World War II
por: Tsai, Jih-Jin, et al.
Publicado: (2018)

Studies on the Vertical Half-Integer Resonance in the CERN PS Booster
por: Prebibaj, Tirsi, et al.
Publicado: (2022)

Predicting anti-RhD titers in donors: Boostering response and decline rates are personal
por: de Vos, Anneke S., et al.
Publicado: (2018)

A new type of half-metallic fully compensated ferrimagnet
por: Semboshi, S., et al.
Publicado: (2022)

Momordica charantia (bitter melon) inhibits primary human adipocyte differentiation by modulating adipogenic genes
por: Nerurkar, Pratibha V, et al.
Publicado: (2010)

Rapid determination of SARS-CoV-2 antibody neutralization titer using Bio-Rad Bio-Plex correlates strongly with pseudovirus-determined neutralization titer
por: Heaps, Amy L., et al.
Publicado: (2023)

Antibody titers and neutralizing activity in cases of COVID-19 after a single dose of vaccination
por: Okumura, Nobumasa, et al.
Publicado: (2022)

In vivo engineered B cells secrete high titers of broadly neutralizing anti-HIV antibodies in mice
por: Nahmad, A. D., et al.
Publicado: (2022)

Antibody titers in turkeys increase after multiple booster vaccinations with an attenuated Salmonella live vaccine
por: Hesse, Martina, et al.
Publicado: (2018)

Correction: Predicting anti-RhD titers in donors: Boostering response and decline rates are personal
por: de Vos, Anneke S., et al.
Publicado: (2018)

Immune evasion and chronological decrease in titer of neutralizing antibody against SARS-CoV-2 and its variants of concerns in COVID-19 patients
por: Takeshita, Masaru, et al.
Publicado: (2022)

Adjudication concerning the Air-conditioning Installations for the Booster
Publicado: (1969)

Anti-feline panleukopenia virus serum neutralizing antibody titer in domestic cats with the negative or low hemagglutination inhibition antibody titer
por: SOMA, Takehisa, et al.
Publicado: (2018)

Comparison of vaccine-induced antibody neutralization against SARS-CoV-2 variants of concern following primary and booster doses of COVID-19 vaccines
por: Hvidt, Astrid K., et al.
Publicado: (2022)

Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition
por: Gilbert, Peter B., et al.
Publicado: (2022)

302. Investigating NAI Titer as a Neutralizing IAV Correlate of Protection
por: Rumfelt, Kalee E, et al.
Publicado: (2023)

Genetic Characteristics and Phylogeny of 969-bp S Gene Sequence of SARS-CoV-2 from Hawaii Reveals the Worldwide Emerging P681H Mutation
por: Maison, David P., et al.
Publicado: (2021)

Effects of a Prolonged Booster Interval on Neutralization of Omicron Variant
por: Zhao, Xin, et al.
Publicado: (2022)

SARS coronavirus spike polypeptide DNA vaccine priming with recombinant spike polypeptide from Escherichia coli as booster induces high titer of neutralizing antibody against SARS coronavirus
por: Woo, Patrick C.Y., et al.
Publicado: (2005)

Significantly elevated antibody levels and neutralization titers in nursing home residents after SARS-CoV-2 BNT162b2 mRNA booster vaccination
por: Canaday, David H., et al.
Publicado: (2021)

A Stabilized, Monomeric, Receptor Binding Domain Elicits High-Titer Neutralizing Antibodies Against All SARS-CoV-2 Variants of Concern
por: Ahmed, Shahbaz, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6c303s1bh88qtj4v3q5bi6t3s9